Author:
Safdari Yaghoub,Ahmadzadeh Vahideh,Farajnia Safar
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference151 articles.
1. Loken MR, Shah VO, Dattilio KL, Civin CI (1987) Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70:1316–1324
2. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, Beaumont T, Tedder TF, van Noesel CJ, Eldering E, van Lier RA (2010) CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 120:214–222
3. Tedder TF, Engel P (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today 15:450–454
4. Winiarska M, Bil J, Nowis D, Golab J (2010) Proteolytic pathways involved in modulation of CD20 levels. Autophagy 6:810–812
5. van Meerten T, Hagenbeek A (2009) CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin’s lymphoma. Neth J Med 67:251–259
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献